10-Q: Quarta-Rad, Inc. Reports First Quarter 2025 Results, Cites Shift to AI-Driven Call Center Solutions

Quarta-Rad, Inc. announces its Q1 2025 financial results, highlighting a strategic shift towards AI-driven call center software development amidst ongoing challenges in its traditional radiation detection device business.

Summary

• Quarta-Rad, Inc. reported its financial results for the quarter ended March 31, 2025.
• The company is shifting its focus from radiation detection devices to AI-driven call center software, specifically the development and marketing of CenterEye.
• Consolidated net revenues increased by $10,845, or 49.20%, to $32,887 for the three months ended March 31, 2025, compared with $22,042 for the three months ended March 31, 2024, primarily due to an increase in Sellavir revenue.
• Cost of goods sold increased by $23,998 or 234.10% to $34,247 for the three months ended March 31, 2025, compared to $10,249 for the comparable period in 2024, due to the increased sales in Sellavir.
• Total operating expenses increased by $14,186 or 19.08% to $88,537 for the three months ended March 31, 2025, compared to $74,351 for the three months ended March 31, 2024, primarily attributable to Sellavirs issuance of stock-based compensation.
• Net loss decreased by $14,242 or 15.54% to $77,409 for the three months ended March 31, 2025 compared to $91,651 for the three months ended March 31, 2024, primarily attributable to Sellavirs increased revenue.
• The company's auditors have raised substantial doubt about its ability to continue as a going concern due to recurring operating losses and limited revenues.
• The company is exploring plans to distribute the current operations in a spin-off.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative. While there is some revenue growth in the Sellavir segment, the company faces significant challenges including a going concern warning, material weaknesses in internal controls, and declining revenue in its core business.

Positives

• Sellavir's revenue increased, contributing to a decrease in the company's net loss.
• The company is strategically focusing on the development of AI-driven call center software, which could provide a new revenue stream.
• The company is seeing traction in Japan for its CenterEye software.
• The company is actively working to expand its Artificial Intelligence business through development of new services and software, and consulting on strategies and implementation.

Negatives

• Quarta-Rad's revenue decreased by 86.90% to $2,887 for the three months ended March 31, 2025, compared with $22,042 for the three months ended March 31, 2024.
• The company has a significant working capital deficit of ($382,103) as of March 31, 2025.
• The company has material weaknesses in its internal control over financial reporting.
• The company's auditors have raised substantial doubt about its ability to continue as a going concern.
• The company has experienced recurring operating losses, primarily due to limited revenues.

Risks

• The company's ability to continue as a going concern is in doubt due to recurring operating losses.
• The company faces risks related to the development and market acceptance of its CenterEye software.
• The company has material weaknesses in its internal control over financial reporting.
• The company's reliance on related party transactions poses a risk.
• The company's ability to purchase inventory from Russia has been impacted by the Russian invasion of Ukraine.

Future Outlook

The company intends to continue investing in the development and marketing of CenterEye, its call center software, and establish partnerships with call center operators and technology resellers. The company is exploring plans to potentially distribute its current operations of both Quarta-Rad and Sellavir and use the company to support operations in alternate services lines.

Management Comments

• The Company is exploring plans to potentially distribute its current operations of both Quarta-Rad and Sellavir and use the company to support operations in alternate services lines.

Industry Context

The company is shifting its focus to the call center software industry, which is experiencing a shift from traditional on-premise solutions to cloud-hosted platforms. This presents an opportunity for Sellavir to introduce a suite of AI-driven products.

Comparison to Industry Standards

• It is difficult to compare Quarta-Rad directly to industry standards due to its unique combination of radiation detection devices and AI-driven call center software.
• However, companies like NICE Ltd., Verint Systems, and Five9, Inc. are established players in the call center software market and serve as benchmarks for Sellavir's CenterEye product.
• These companies have significantly higher revenue and market capitalization compared to Quarta-Rad.

Management Changes

Related Party Transactions

• The Company sells radiation monitors and to date purchased all of it inventory from Quarta-Rad, LTD (QRR), a company in Russia, which is owned by the Company's minority shareholder, who disposed of their interest in 2024, through 2022.
• In May 2022, the Company began using Star Systems Corporation (STAR:), a Japanese entity owned by the Company's majority shareholder, as an intermediary to purchase inventory from QRR.
• The Company owes STAR $ 42,502 and $ 42,502 on March 31,2025, and December 31, 2024, for purchasers and inventory and upgrades from 2022.
• During July 2017 the Company entered into an agreement with the Russian affiliate to develop and update software for a new device for $ 180,000 .
• In April 2021, the Company began compensating its CEO, who is the majority shareholder.
• From time to time the CEO advanced funds for operations.
• Sellavir recognized $ 30,000 and $0 of revenue for the three months ended March 31, 2025, and 2024, respectively in services to STAR to develop software.
• During March 2025, Sellavir also received $ 20,000 in development fees, for services to be performed, recorded as deferred revenue.
• During March 2025, the Company made the determination that the second note of $ 164,375 and accrued interest of approximately $ 35,000 was assigned to the Company's CEO and majority shareholder to satisfy certain obligations outstanding.

Stakeholder Impact

• Shareholders face uncertainty due to the company's going concern warning and material weaknesses in internal controls.
• Employees may be affected by the company's strategic shift and potential restructuring.
• Customers of Quarta-Rad may experience disruptions due to the company's focus on AI-driven call center solutions.
• Suppliers may be impacted by the company's changing inventory sourcing and strategic direction.
• Creditors face increased risk due to the company's financial difficulties.

Next Steps

• The company intends to purchase inventory to increase sales.
• The company will continue to invest in the development and enhancement of CenterEye.
• The company intends to increase marketing efforts on the Internet to generate leads and sales.
• The company aims to establish partnerships with call center operators and technology resellers.

Key Dates

Keywords

CenterEye, Sellavir, Quarta-Rad, AI, call center software, financial results, radiation detection, internal control, going concern